Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is AZILSARTAN KAMEDOXOMIL, with a corresponding US DMF Number 35770.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 13, 2021, and payment made on August 26, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II